Related Experiment Video
Updated: Jun 11, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Vitamin B12 responsive developmental and epileptic encephalopathy due to a novel mutation in the FUT2 gene: a case
Pkbuc Bandara1, Wasana Wijenayake1, Sanjaya Fernando1
1Colombo North Teaching Hospital, Ragama, Sri Lanka.
Insights
A novel mutation in the FUT2 gene caused vitamin B12 deficiency, leading to developmental and epileptic encephalopathy in an infant. Prompt genetic testing identified this treatable condition, improving seizure control and development.
Area of Science:
- Genetics and Molecular Biology
- Pediatric Neurology
- Nutritional Science
Background:
- Vitamin B12 deficiency is a known cause of neurological issues, but rarely presents as developmental and epileptic encephalopathy.
- This case highlights a rare genetic cause of severe infantile epilepsy and developmental regression.
Observation:
- An 11-month-old infant presented with refractory infantile epileptic spasms and severe developmental delay, unresponsive to multiple anti-seizure medications.
- Clinical findings included macrocytic anemia and megaloblastic bone marrow, suggesting a B12 or folate pathway disorder.
Findings:
- Whole exome sequencing identified a novel homozygous missense variant in the FUT2 gene, confirming vitamin B12 deficiency due to impaired absorption.
- Treatment with intramuscular hydroxocobalamin resulted in a significant reduction in seizure frequency and improved developmental trajectory.
Implications:
- This case underscores the critical importance of considering treatable metabolic and genetic disorders in infants with refractory developmental and epileptic encephalopathy.
- Timely genetic diagnosis of FUT2 mutations can lead to effective treatment with vitamin B12 supplementation, preventing irreversible neurological damage.
Background:
Vitamin B12 deficiency is a recognised cause of neurological manifestations, including peripheral neuropathy, behavioural changes, and seizures. However, developmental and epileptic encephalopathy due to vitamin B12 deficiency is very rare. Here, we report an infant with vitamin B12-responsive developmental and epileptic encephalopathy due to a novel mutation in the fucosyltransferase 2 (FUT2) gene responsible for vitamin B12 absorption.
Case Presentation:
An 11-month-old girl of non-consanguineous parents presented with recurrent episodes of seizures since four months. Her seizures started as flexor epileptic spasms occurring in clusters resembling infantile epileptic spasms syndrome with hypsarrhythmia in the electroencephalogram. She was treated with multiple drugs, including high-dose prednisolone, vigabatrin, sodium valproate, levetiracetam and clobazam, without any response, and she continued to have seizures at 11 months. She had an early developmental delay with maximally achieving partial head control and responsive smile at four months. Her development regressed with the onset of seizure; at 11 months, her developmental age was below six weeks. On examination, she was pale and had generalised hypotonia with normal muscle power and reflexes. Her full blood count and blood picture revealed macrocytic anaemia with oval and round macrocytes. Bone marrow aspiration showed hypercellular marrow erythropoiesis with normoblastic and megaloblastic maturation. Due to the unusual association of refractory epilepsy and megaloblastic anaemia, a rare genetic disease of the vitamin B12 or folate pathways was suspected. The whole exome sequencing revealed a homozygous missense variant in exon 2 of the FUT2 gene associated with reduced vitamin B12 absorption and low plasma vitamin B12 levels, confirming the diagnosis of vitamin B12 deficiency related developmental and epileptic encephalopathy. She was started on intramuscular hydroxocobalamin, for which she showed a marked response with reduced seizure frequency.
Conclusion:
We report a novel variant in the FUT2 gene associated with vitamin B12-responsive developmental and epileptic encephalopathy and megaloblastic anaemia. This case report highlights the importance of timely genetic testing in children with refractory developmental and epileptic encephalopathy to identify treatable causes.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Inborn Errors of Metabolism
Pedigree Analysis
ATP Synthase: Structure
Lysosomal Hydrolases